Dow Up 0.15% Nasdaq Up 0.21%

Immunomedics Inc. (IMMU)

-NasdaqGM
3.28 Up 0.01(0.31%) 4:00PM EDT
Prev Close:3.27
Open:3.25
Bid:3.07 x 2000
Ask:3.30 x 100
1y Target Est:7.00
Beta:0.71
Next Earnings Date:N/A
Day's Range:3.08 - 3.36
52wk Range:3.04 - 7.35
Volume:629,623
Avg Vol (3m):472,553
Market Cap:305.41M
P/E (ttm):N/A
EPS (ttm):-0.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IMMUUp 0.31%305.41M
BIIBUp 0.21%77.36B
GSKDown 0.42%113.13B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):33.68
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.52
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback